XENE icon

Xenon Pharmaceuticals
XENE

Overview Fund Activity

209 hedge funds and large institutions have $2.99B invested in Xenon Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 66 increasing their positions, 69 reducing their positions, and 20 closing their positions.

Holders
209
Holders Change
+7
Holders Change %
+3.47%
% of All Funds
2.78%
Holding in Top 10
13
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+44.44%
% of All Funds
0.17%
New
29
Increased
66
Reduced
69
Closed
20
Calls
$4.36M
Puts
$82K
Net Calls
+$4.28M
Net Calls Change
+$636K

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$295M
2
Westfield Capital Management
2
Westfield Capital Management
Massachusetts
$45.4M
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$53.2M
4
SC
4
Stempoint Capital
New York
$14.7M
5
FTM
5
First Turn Management
California
$26.9M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$12.8M
2
Capital World Investors
2
Capital World Investors
California
$89.9M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$0
4
APM
4
Avidity Partners Management
Texas
$18.6M
5
Marshall Wace
5
Marshall Wace
United Kingdom
$35.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
WWM
226
Wolff Wiese Magana
California
– -$2.4K -61 Closed
PD
227
Point72 (DIFC)
United Arab Emirates
– -$1.34K -34 Closed
PPC
228
Park Place Capital
Alabama
– -$709 -18 Closed
AAP
229
Arax Advisory Partners
Colorado
– -$119 -3 Closed
6 7 8 9
10